Articles:

Monitoring of p53 autoantibodies in lung cancer during therapy: relationship to response to treatment

G Zalcman, B Schlichtholz, J Tredaniel, T Urban, R Lubin, I Dubois, B Milleron, A Hirsch, and T Soussi
Clin Cancer Res 1998 4: 1359 [Abstract] [PDF]  

Improved targeting of brain tumors using dexrazoxane rescue of topoisomerase II combined with supralethal doses of etoposide and teniposide

B Holm, M Sehested, and PB Jensen
Clin Cancer Res 1998 4: 1367 [Abstract] [PDF]  

Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis

H Porte, JP Triboulet, L Kotelevets, F Carrat, S Prevot, B Nordlinger, Y DiGioia, A Wurtz, P Comoglio, C Gespach, and E Chastre
Clin Cancer Res 1998 4: 1375 [Abstract] [PDF]  

Epidermal growth factor receptor expression in cervical intraepithelial neoplasia and its modulation during an alpha-difluoromethylornithine chemoprevention trial

IV Boiko, MF Mitchell, W Hu, DK Pandey, P Mathevet, A Malpica, and WN Hittelman
Clin Cancer Res 1998 4: 1383 [Abstract] [PDF]  

The expression of drug resistance gene products during the progression of human prostate cancer

GF Sullivan, PS Amenta, JD Villanueva, CJ Alvarez, JM Yang, and WN Hait
Clin Cancer Res 1998 4: 1393 [Abstract] [PDF]  

4-(3'-Bromo-4'hydroxylphenyl)-amino-6,7-dimethoxyquinazoline: a novel quinazoline derivative with potent cytotoxic activity against human glioblastoma cells

RK Narla, XP Liu, DE Myers, and FM Uckun
Clin Cancer Res 1998 4: 1405 [Abstract] [PDF]  

Analysis of DNA mismatch repair proteins in human medulloblastoma

SE Lee, SP Johnson, LP Hale, J Li, N Bullock, H Fuchs, A Friedman, R McLendon, DD Bigner, P Modrich, and HS Friedman
Clin Cancer Res 1998 4: 1415 [Abstract] [PDF]  

Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia

PC Caron, L Dumont, and DA Scheinberg
Clin Cancer Res 1998 4: 1421 [Abstract] [PDF]  

Renal clearance, tissue distribution, and CA-125 responses in a phase I trial of suramin

PR Hutson, KD Tutsch, R Rago, R Arzoomanian, D Alberti, M Pomplun, D Church, R Marnocha, AL Cheng, N Kehrli, and G Wilding
Clin Cancer Res 1998 4: 1429 [Abstract] [PDF]  

Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer

NA Rizvi, JL Marshall, E Ness, J Yoe, GM Gill, JA Truglia, GR Loewen, D Jaunakais, EH Ulm, and MJ Hawkins
Clin Cancer Res 1998 4: 1437 [Abstract] [PDF]  

Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell support

AD Elias, C Wheeler, LJ Ayash, G Schwartz, J Ibrahim, L Mills, M McCauley, N Coleman, D Warren, L Schnipper, KH Antman, BA Teicher, and E Frei, 3rd
Clin Cancer Res 1998 4: 1443 [Abstract] [PDF]  

Phase II study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimen

E Warner, D Hedley, I Andrulis, R Myers, M Trudeau, D Warr, KI Pritchard, M Blackstein, PE Goss, E Franssen, K Roche, S Knight, S Webster, RA Fraser, S Oldfield, W Hill, and R Kates
Clin Cancer Res 1998 4: 1451 [Abstract] [PDF]  

A phase I and translational study of sequential administration of the topoisomerase I and II inhibitors topotecan and etoposide

LA Hammond, JR Eckardt, R Ganapathi, HA Burris, GA Rodriguez, SG Eckhardt, ML Rothenberg, GR Weiss, JG Kuhn, S Hodges, DD Von Hoff, and EK Rowinsky
Clin Cancer Res 1998 4: 1459 [Abstract] [PDF]  

Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinum

N Boku, K Chin, K Hosokawa, A Ohtsu, H Tajiri, S Yoshida, T Yamao, H Kondo, K Shirao, Y Shimada, D Saito, T Hasebe, K Mukai, S Seki, H Saito, and PG Johnston
Clin Cancer Res 1998 4: 1469 [Abstract] [PDF]  

Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis

K Mise, S Tashiro, S Yogita, D Wada, M Harada, Y Fukuda, H Miyake, M Isikawa, K Izumi, and N Sano
Clin Cancer Res 1998 4: 1475 [Abstract] [PDF]  

Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma

T Shibusa, N Shijubo, and S Abe
Clin Cancer Res 1998 4: 1483 [Abstract] [PDF]  

Prognostic value of prostate-specific antigen for women with breast cancer: a large United States cohort study

H Yu, MA Levesque, GM Clark, and EP Diamandis
Clin Cancer Res 1998 4: 1489 [Abstract] [PDF]  

p21waf1/cip1 and transforming growth factor beta 1 protein expression correlate with survival in non-small cell lung cancer

WP Bennett, WS el-Deiry, WL Rush, DG Guinee, Jr, AN Freedman, NE Caporaso, JA Welsh, RT Jones, A Borkowski, WD Travis, MV Fleming, V Trastek, PC Pairolero, HD Tazelaar, D Midthun, JR Jett, LA Liotta, and CC Harris
Clin Cancer Res 1998 4: 1499 [Abstract] [PDF]  

Motility related protein 1 (MRP1/CD9) expression in colon cancer

M Mori, K Mimori, T Shiraishi, M Haraguchi, H Ueo, GF Barnard, and T Akiyoshi
Clin Cancer Res 1998 4: 1507 [Abstract] [PDF]  

Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer

J Kos, HJ Nielsen, M Krasovec, IJ Christensen, N Cimerman, RW Stephens, and N Brunner
Clin Cancer Res 1998 4: 1511 [Abstract] [PDF]  

Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias

K Sonoda, T Kaku, T Kamura, M Nakashima, T Watanabe, and H Nakano
Clin Cancer Res 1998 4: 1517 [Abstract] [PDF]  

CD28, a marker associated with tumoral expansion in multiple myeloma

N Robillard, G Jego, C Pellat-Deceunynck, D Pineau, D Puthier, MP Mellerin, S Barille, MJ Rapp, JL Harousseau, M Amiot, and R Bataille
Clin Cancer Res 1998 4: 1521 [Abstract] [PDF]  

Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features

T Yamada, S Nakamori, H Ohzato, S Oshima, T Aoki, N Higaki, K Sugimoto, K Akagi, Y Fujiwara, I Nishisho, M Sakon, M Gotoh, and M Monden
Clin Cancer Res 1998 4: 1527 [Abstract] [PDF]  

Quantitative reverse transcriptase-polymerase chain reaction measured expression of MDR1 and MRP in primary breast carcinoma

DW Dexter, RK Reddy, KG Geles, S Bansal, MA Myint, A Rogakto, JC Leighton, and LJ Goldstein
Clin Cancer Res 1998 4: 1533 [Abstract] [PDF]  

Flow cytometric DNA analyses of benign breast lesions detected by screening mammography

PC Stomper, JR DeBloom, 2nd, RM Budnick, and CC Stewart
Clin Cancer Res 1998 4: 1543 [Abstract] [PDF]  

Differential permeability of a human brain tumor xenograft in the nude rat: impact of tumor size and method of administration on optimizing delivery of biologically diverse agents

EA Neuwelt, PA Barnett, CI McCormick, LG Remsen, RA Kroll, and G Sexton
Clin Cancer Res 1998 4: 1549 [Abstract] [PDF]  

The growth inhibitory effect of N1,N12-bis(ethyl)spermine in small cell lung cancer cells is maintained in cells expressing the c-myc and Ha-ras oncogenes

LF Barr, SE Campbell, P Tamez, and RA Casero, Jr
Clin Cancer Res 1998 4: 1557 [Abstract] [PDF]  

Potential interactions between antitubulin agents and temperature: implications for modulation of multidrug resistance

C Dumontet, F Bodin, and Y Michal
Clin Cancer Res 1998 4: 1563 [Abstract] [PDF]  

Efficacy of pyridoxine to ameliorate the cutaneous toxicity associated with doxorubicin containing pegylated (Stealth) liposomes: a randomized, double-blind clinical trial using a canine model

DM Vail, R Chun, DH Thamm, LD Garrett, AJ Cooley, and JE Obradovich
Clin Cancer Res 1998 4: 1567 [Abstract] [PDF]  

Telomerase activity of sarcoma cell lines and fibroblasts is independent of p53 status

M Milas, D Yu, D Sun, and RE Pollock
Clin Cancer Res 1998 4: 1573 [Abstract] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.